-
Press Release
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
-
Story
A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis -
Story
How collaboration can enhance your science career -
Press Release
Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in Indianapolis
-
Story
Innovation fueled by compassion -
Press Release
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
-
Story
In neuroscience, “an inflection point in knowledge and technology” -
Press Release
Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
-
Story
A shared mission to take on the “impossible” in cancer research -
Story
The art of drug design in a technological age -
Story
Stopping this coronavirus – and the next one -
Story
Toward regrowing cartilage